These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 23501055

  • 21. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
    HoWangYin KY, Loinard C, Bakker W, Guérin CL, Vilar J, d'Audigier C, Mauge L, Bruneval P, Emmerich J, Lévy BI, Pouysségur J, Smadja DM, Silvestre JS.
    Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J, Li G, Wang Y, Tang S, Sun X, Feng X, Li Y, Bao G, Li P, Mao X, Wang M, Liu P.
    Oncotarget; 2015 Dec 29; 6(42):44579-92. PubMed ID: 26625311
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 27. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
    Han WQ, Zhu Q, Hu J, Li PL, Zhang F, Li N.
    Biochim Biophys Acta; 2013 Jun 16; 1833(6):1454-62. PubMed ID: 23466866
    [Abstract] [Full Text] [Related]

  • 28. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation.
    Park YK, Ahn DR, Oh M, Lee T, Yang EG, Son M, Park H.
    Mol Pharmacol; 2008 Jul 16; 74(1):236-45. PubMed ID: 18426857
    [Abstract] [Full Text] [Related]

  • 29. Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.
    Thapa D, Kang Y, Park PH, Noh SK, Lee YR, Han SS, Ku SK, Jung Y, Kim JA.
    Biol Pharm Bull; 2012 Jul 16; 35(6):924-32. PubMed ID: 22687485
    [Abstract] [Full Text] [Related]

  • 30. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
    Paradziej-Łukowicz J, Skwarska A, Peszyńska-Sularz G, Brillowska-Dąbrowska A, Konopa J.
    Cancer Biol Ther; 2011 Oct 01; 12(7):586-97. PubMed ID: 21775820
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
    Jones MK, Szabó IL, Kawanaka H, Husain SS, Tarnawski AS.
    FASEB J; 2002 Feb 01; 16(2):264-6. PubMed ID: 11772947
    [Abstract] [Full Text] [Related]

  • 37. Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.
    Takei A, Ekström M, Mammadzada P, Aronsson M, Yu M, Kvanta A, André H.
    Sci Rep; 2017 Feb 10; 7():42546. PubMed ID: 28186209
    [Abstract] [Full Text] [Related]

  • 38. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM, Gao D, Trahan DN, Johnson BA, Ludwig A, Barbieri E, Chen Z, Diaz-Miron J, Vassilev L, Shohet JM, Kim ES.
    Angiogenesis; 2011 Sep 10; 14(3):255-66. PubMed ID: 21484514
    [Abstract] [Full Text] [Related]

  • 39. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
    Chen MC, Hsu WL, Chang WL, Chou TC.
    Sci Rep; 2017 Jul 14; 7(1):5376. PubMed ID: 28710377
    [Abstract] [Full Text] [Related]

  • 40. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ, Tian YM, Mole DR, Harris AL.
    Circ Res; 2004 Jul 23; 95(2):162-9. PubMed ID: 15192023
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.